Authors:
GRIBKOFF VK
PIESCHL RL
WISIALOWSKI TA
VANDENPOL AN
YOCCA FD
Citation: Vk. Gribkoff et al., PHASE-SHIFTING OF CIRCADIAN-RHYTHMS AND DEPRESSION OF NEURONAL-ACTIVITY IN THE RAT SUPRACHIASMATIC NUCLEUS BY NEUROPEPTIDE-Y - MEDIATION BYDIFFERENT RECEPTOR SUBTYPES, The Journal of neuroscience, 18(8), 1998, pp. 3014-3022
Authors:
SAXENA PR
DEVRIES P
HEILIGERS JPC
BAX WA
VANDENBRINK AM
YOCCA FD
Citation: Pr. Saxena et al., BMS-181885, A 5-HT1B 1D RECEPTOR-LIGAND, IN EXPERIMENTAL-MODELS PREDICTIVE OF ANTIMIGRAINE ACTIVITY AND CORONARY SIDE-EFFECT POTENTIAL/, European journal of pharmacology, 351(3), 1998, pp. 329-339
Authors:
SAXENA PR
DEVRIES P
WANG W
HEILIGERS JPC
VANDENBRINK AM
BAX WA
YOCCA FD
Citation: Pr. Saxena et al., EFFECTS OF AVITRIPTAN, A NEW 5-HT1B 1D RECEPTOR AGONIST, IN EXPERIMENTAL-MODELS PREDICTIVE OF ANTIMIGRAINE ACTIVITY AND CORONARY SIDE-EFFECT POTENTIAL/, Naunyn-Schmiedeberg's archives of pharmacology, 355(2), 1997, pp. 295-302
Citation: Ff. Matos et al., SEROTONIN (5-HT) RELEASE IN THE DORSAL RAPHE AND VENTRAL HIPPOCAMPUS - RAPHE CONTROL OF SOMATODENDRITIC AND 5-HT RELEASE, Journal of neural transmission, 103(1-2), 1996, pp. 173-190
Citation: Wp. Clarke et al., LACK OF 5-HYDROXYTRYPTAMINE(1A)-MEDIATED INHIBITION OF ADENYLYL-CYCLASE IN DORSAL RAPHE OF MALE AND FEMALE RATS, The Journal of pharmacology and experimental therapeutics, 277(3), 1996, pp. 1259-1266
Citation: Ff. Matos et al., 5-HT1A RECEPTOR AGONIST EFFECTS OF BMY-14802 ON SEROTONIN RELEASE IN DORSAL RAPHE AND HIPPOCAMPUS, European journal of pharmacology, 317(1), 1996, pp. 49-54
Citation: Fd. Yocca et al., EFFECT OF EMS-180048 ON CAROTID ARTERIAL BLOOD-FLOW AND ARTERIOVENOUSBLOOD-OXYGEN CONTENT IN THE ANESTHETIZED DOG, The FASEB journal, 9(3), 1995, pp. 23-23
Authors:
MYERS RA
SARBIN NS
KAPIN MA
YOCCA FD
ELSON MS
Citation: Ra. Myers et al., MODULATION OF FELINE CEPHALIC ARTERIOVENOUS SHUNTING AND SYSTEMIC HEMODYNAMICS FOLLOWING ADMINISTRATION OF BMS-180048 AND SUMATRIPTAN, The FASEB journal, 9(3), 1995, pp. 23-23
Authors:
SARBIN NS
GYLYS JA
IBEN LG
MAHLE CD
IZZARELLI DG
PARKER EM
NOONAN JW
WILLIAMS AD
SMITH DW
HAMEL E
YOCCA FD
Citation: Ns. Sarbin et al., THE RECEPTOR-BINDING AND VASCULAR IN-VITRO PHARMACOLOGICAL PROFILE OFBMS-180048, A NOVEL ANTIMIGRAINE AGENT, The FASEB journal, 9(3), 1995, pp. 347-347
Citation: Hl. Wiener et al., KINETIC CHARACTERIZATION OF THE RESPONSES TO BMS-180048, A NOVEL ANTIMIGRAINE AGENT, IN CEREBRAL BLOOD-VESSELS, The FASEB journal, 9(3), 1995, pp. 347-347
Authors:
TAYLOR DP
CARTER RB
EISON AS
MULLINS UL
SMITH HL
TORRENTE JR
WRIGHT RN
YOCCA FD
Citation: Dp. Taylor et al., PHARMACOLOGY AND NEUROCHEMISTRY OF NEFAZODONE, A NOVEL ANTIDEPRESSANTDRUG, The Journal of clinical psychiatry, 56, 1995, pp. 3-11
Authors:
PARKER EM
GRISEL DA
IBEN LG
NOWAK HP
MAHLE CD
YOCCA FD
GAUGHAN GT
Citation: Em. Parker et al., CHARACTERIZATION OF HUMAN 5-HT1 RECEPTORS EXPRESSED IN SF9 INSECT CELLS, European journal of pharmacology. Molecular pharmacology section, 268(1), 1994, pp. 43-53
Citation: Lg. Iben et al., DIFFERENTIAL SENSITIVITY OF H-3 AGONIST BINDING TO PRESYNAPTIC AND POSTSYNAPTIC 5-HT1A RECEPTORS IN BOVINE BRAIN, British Journal of Pharmacology, 113(4), 1994, pp. 1400-1406
Authors:
GEISSLER MA
TORRENTE JR
EISON AS
GYLYS JA
WRIGHT RN
IBEN LG
DAVIS HH
YOCCA FD
Citation: Ma. Geissler et al., EFFECTS OF BMY-33462, A SELECTIVE AND POTENT SEROTONIN TYPE-3 RECEPTOR ANTAGONIST, ON MESOLIMBIC DOPAMINE-MEDIATED BEHAVIOR, Drug development research, 29(1), 1993, pp. 18-24
Citation: K. Bohmaker et al., COMPARATIVE EFFECTS OF CHRONIC 8-OH-DPAT, GEPIRONE AND IPSAPIRONE TREATMENT ON THE SENSITIVITY OF SOMATODENDRITIC 5-HT1A AUTORECEPTORS, Neuropharmacology, 32(6), 1993, pp. 527-534
Authors:
WISDEN W
PARKER EM
MAHLE CD
GRISEL DA
NOWAK HP
YOCCA FD
FELDER CC
SEEBURG PH
VOIGT MM
Citation: W. Wisden et al., CLONING AND CHARACTERIZATION OF THE RAT 5-HT(5B)RECEPTOR - EVIDENCE THAT THE 5-HT(5B)RECEPTOR COUPLES TO A G-PROTEIN IN MAMMALIAN-CELL MEMBRANES, FEBS letters, 333(1-2), 1993, pp. 25-31
Citation: Hp. Nowak et al., [H-3] 5-CARBOXAMIDOTRYPTAMINE LABELS 5-HT1D BINDING-SITES IN BOVINE SUBSTANTIA-NIGRA, British Journal of Pharmacology, 109(4), 1993, pp. 1206-1211